HF
IART icon

Hoxton Financial’s Integra LifeSciences IART Stock Holding History

Hoxton Financial’s Portfolio IART Stock Details IART Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q1 		– Sell
-1,226
Closed -$24K – 467
2013
Q4 		$24K Buy
1,226
+477
+64% +$8.75K 0.01% 315
2013
Q3 		$12K Buy
749
+13
+2% +$209 0.01% 256
2013
Q2 		$11K Buy
+736
New +$10.8K 0.01% 390

Other funds holding IART

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
VNIM
Vaughan Nelson Investment Management Houston, Texas $11.3B AUM 53% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
EIP
Epoch Investment Partners New York $16.5B AUM 24.3% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

Hoxton Financial's IART Position: Q1 2014 in Review

Hoxton Financial sold out of Integra LifeSciences (IART) in Q1 2014, closing a stake of 1,226 shares — an estimated $24K sold.

Hoxton Financial first reported a position in IART in Q2 2013 and held it in 3 quarters. The position peaked at $24K in Q4 2013. 144 funds tracked by Wall St. Rank hold IART as of Q1 2014.

  • Hoxton Financial reported no remaining Integra LifeSciences position as of Q1 2014 after selling out during the quarter.
  • Hoxton Financial sold 1,226 Integra LifeSciences shares in Q1 2014, an estimated $24K.
  • Hoxton Financial first reported a position in Integra LifeSciences in Q2 2013 and held it in 3 quarters.
  • Hoxton Financial's Integra LifeSciences position peaked at $24K in Q4 2013.
  • 144 funds tracked by Wall St. Rank held Integra LifeSciences as of Q1 2014.

Based on Hoxton Financial's 13F filing for Q1 2014, filed 25 Apr 2014.